INS and Hypoglycemia: In this sense, insulin antibodies (IAs) have been identified in diabetic patients for regular insulin treatments, and are associated with exogenous insulin antibody syndrome (EIAS) that is characterized by insulin resistance with hyperglycemia or hypoglycemia.